Inactive Instrument

Insiders Oncomed Pharmaceuticals Inc

Equities

OncoMed Pharmaceuticals, Inc. Announces Executive Resignations in Connection with the Merger Agreement	19-04-23	CI
Oncomed Pharmaceuticals, Inc. Announces Executive Changes	18-12-06	CI
OncoMed Pharmaceuticals, Inc. Announces Resignation of Denise Scots-Knight as Member of the Board	18-10-01	CI
OncoMed Pharmaceuticals Names John Lewicki as CEO, President, and Member of the Board of Directors	18-03-19	CI
OncoMed Pharmaceuticals, Inc. Appoints Yvonne Li as Principal Accounting Officer and Principal Financial Officer	18-03-19	CI
OncoMed Pharmaceuticals, Inc. Announces Executive Changes	18-01-31	CI
OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings has Resigned	18-01-04	GL
OncoMed Pharmaceuticals, Inc. Announces Management Changes	18-01-04	CI
OncoMed Pharmaceuticals, Inc. Announces Management Changes	17-11-27	CI
OncoMed Pharmaceuticals Chairman and CEO, Paul Hastings, to Take Medical Leave of Absence and Office of the President Established to Lead Company During Medical Leave	17-09-19	CI
OncoMed Pharmaceuticals, Inc. Announces Executive Changes	16-12-05	CI
OncoMed Pharmaceuticals, Inc. Appoints Perry Karsen to the Board of Directors	16-01-06	CI
OncoMed Pharmaceuticals, Inc. Appoints Rick Winningham to Board of Directors	15-06-29	CI
OncoMed Pharmaceuticals, Inc. Appoints Michael Wyzga as Independent Director and Chairman of Audit Committee	13-10-17	CI

No results for this search